Thermo Fisher Scientific to Sell its Cell Culture, Gene Modulation and Magnetic Beads Businesses to GE Healthcare for $1.06B
January 06, 2014 at 07:01 AM EST
Thermo Fisher Scientific (NYSE: TMO ) today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit
